Chenxing Du, MD, PhD (she/her/hers)

Doctor
Institute of Hematology and Blood Diseases Hospital
Tianjin, Tianjin, China (People's Republic)

Attending physician
Department of Lymphoma and Myeloma,
Institute of Hematology and Blood Diseases Hospital,
Chinese Academy of Medical Sciences
Major in genetics and mechanism of drug resistance of multiple myeloma

Disclosure information not submitted.

Presentation(s):

• (OA-16) BCMA CAR T-Cell Therapy in Newly Diagnosed Primary Plasma Cell Leukemia Ineligible for Transplantation: An Open Label, Single-arm, Phase 2 Study (CAREMM-002)

  Friday, September 19, 2025
  13:19 - 13:37 East Coast USA Time